0001415889-22-004339.txt : 20220428 0001415889-22-004339.hdr.sgml : 20220428 20220428213422 ACCESSION NUMBER: 0001415889-22-004339 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220426 FILED AS OF DATE: 20220428 DATE AS OF CHANGE: 20220428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YOUNG WILLIAM D CENTRAL INDEX KEY: 0001217420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 22869697 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-04282022_060430.xml X0306 4 2022-04-26 0001583107 Theravance Biopharma, Inc. TBPH 0001217420 YOUNG WILLIAM D C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 true false false false Ordinary Shares 2022-04-26 4 A 0 9852 0 A 78010 D Share Option (Right to Buy) 10.15 2022-04-26 4 A 0 28000 0 A 2032-04-25 Ordinary Shares 28000 28000 D This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. /s/ Brett A. Grimaud, Attorney-in-Fact 2022-04-28